Exogenous 3-Deoxyglucosone-Induced Carbonyl and Oxidative Stress Causes β-Cells Dysfunction by Impairing Gut Permeability in Rats


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

3-Deoxyglucosone (3DG) is a highly reactive dicarbonyl species, and its accumulation evokes carbonyl and oxidative stress. Our recent data reveal the role of 3DG as an independent factor for the development of prediabetes and suggest that intestine could be its novel target tissue. The present study investigated whether exogenous 3DG increases intestinal permeability by triggering carbonyl and oxidative stress, thus contributing to β-cell dysfunction. Rats were administered 3DG for two weeks by gastric gavage. Then levels of insulin, ROS, MDA, SOD, NLRP3, TNF-α and IL-1β in blood plasma as well as the ROS level and content of TNF-α and IL-1β in pancreas were assessed. Also, the expression of E-cadherin and ZO-1 as well as levels of 3DG, protein carbonylation, ROS, TNF-α and IL-1β in colon were determined. The 3DG-treated rats showed an elevation in systemic oxidative stress (ROS, MDA and SOD) and in inflammation (TNF-α and IL-1β), decreased plasma insulin level 15 min after the glucose load, and increased levels of TNF-α, IL-1β and ROS in pancreatic tissue. In colon tissues of the 3DG-treated rats, decreased E-cadherin expression and increased ROS production as well as an elevation of TNF-α and IL-1β levels were observed. Interestingly, elevation of colon protein carbonylation was observed in the 3DG-treated rats that displayed 3DG deposition in colon tissues. We revealed for the first time that 3DG deposition in colon triggers carbonyl and oxidative stress and, as a consequence, impairs gut permeability. The enhanced intestinal permeability caused by 3DG deposition in colon results in systemic and pancreatic oxidative stress and inflammatory process, contributing to the development of β-cell dysfunction.

Sobre autores

L. Zhou

Suzhou Academy of Wumen Chinese Medicine

Email: szguorongjiang@163.com
República Popular da China, Suzhou, Jiangsu

X. Song

Suzhou Academy of Wumen Chinese Medicine

Email: szguorongjiang@163.com
República Popular da China, Suzhou, Jiangsu

H. Xu

Suzhou Academy of Wumen Chinese Medicine

Email: szguorongjiang@163.com
República Popular da China, Suzhou, Jiangsu

G. Liang

Suzhou Academy of Wumen Chinese Medicine

Email: szguorongjiang@163.com
República Popular da China, Suzhou, Jiangsu

F. Wang

Suzhou Academy of Wumen Chinese Medicine

Email: szguorongjiang@163.com
República Popular da China, Suzhou, Jiangsu

L. Zhang

Suzhou Academy of Wumen Chinese Medicine

Email: szguorongjiang@163.com
República Popular da China, Suzhou, Jiangsu

F. Huang

Suzhou Academy of Wumen Chinese Medicine

Email: szguorongjiang@163.com
República Popular da China, Suzhou, Jiangsu

J. Cai

Suzhou Academy of Wumen Chinese Medicine

Email: szguorongjiang@163.com
República Popular da China, Suzhou, Jiangsu

G. Jiang

Suzhou Academy of Wumen Chinese Medicine

Autor responsável pela correspondência
Email: szguorongjiang@163.com
República Popular da China, Suzhou, Jiangsu


Declaração de direitos autorais © Pleiades Publishing, Ltd., 2018

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies